US Patent Issued to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, IMMUNE-ONC THERAPEUTICS on April 7 for "LILRB2 antibodies and uses thereof" (Texas, California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,596,122, issued on April 7, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas) and IMMUNE-ONC THERAPEUTICS INC. (Palo Alto, Calif.).

"LILRB2 antibodies and uses thereof" was invented by Zhiqiang An (Houston), Ningyan Zhang (Houston), Zhiqiang Ku (Houston), Chengcheng Zhang (Southlake, Texas), Xiaoye Liu (Dallas), Heyu Chen (Dallas), JingJing Xie (Plano, Texas), Maria Jose Costa (Palo Alto, Texas), An Song (Palo Alto, Texas) and X. Charlene Liao (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies binding to LILRB2 and the uses of the antibodies in detecting and treating canc...